GLIPR1 and central nervous system cancer: It has been found that DNA hypomethylation of the GLIPR1 gene promoter led to its overexpression in glioma [15] and wilms [20] tumors, whereas hypermethylation of the GLIPR1 gene promoter led to the downregulation of its mRNA expression in prostate cancer [9].